Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV-NIRD1 pharmacokinetic optical imaging study in healthy volunteers
NL-OMON42729Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- May 2016
- Modality
- Vaccines & Immunotherapeutics, Peptides
- Countries
- 1
01
Overview
Open-label trial of HPV-NIRD1 in Human Papillomavirus 16-Associated Cancer (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Treatment-emergent adverse events, Concomitant medication and 6 more. Started May 2016; status: active, not recruiting.
02
Drugs
HPV-NIRD1
03
Conditions
Human Papillomavirus 16-Associated Cancer
Beyond the preview
Go deeper on NL-OMON42729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42729.